Biopharmaceutical CMO and CRO Market (By Source: Non-mammalian, Mammalian; By Service Type: Contract Manufacturing [Process Development, Analytical & QC studies, Finish & Fill Operations, Packaging], Contract Research [Oncology, Cardiology, Neuroscience, Inflammation & Immunology, Others; By Product: Biosimilars, Biologics [Monoclonal Antibodies (MAbs), Recombinant Proteins, Vaccines, Antisense, RNAi, & Molecular Therapy, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format: PDF | Status: Published | Pages : 190

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Biopharmaceutical CMO and CRO
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Biopharmaceutical CMO and CRO Market By Source
1.2.2.1. Global Biopharmaceutical CMO and CRO Market Revenue and Growth Rate Comparison By Source (2015-2026)
1.2.2.2. Global Biopharmaceutical CMO and CRO Market Revenue Share By Source in 2017
1.2.2.3. Non-mammalian
1.2.2.4. Mammalian
1.2.3. Biopharmaceutical CMO and CRO Market By Service Type
1.2.3.1. Global Biopharmaceutical CMO and CRO Market Revenue and Growth Rate Comparison By Service Type (2015-2026)
1.2.3.2. Contract Manufacturing
1.2.3.2.1. Process Development
1.2.3.2.2. Analytical & QC studies
1.2.3.2.3. Finish & Fill Operations
1.2.3.2.4. Packaging
1.2.3.3. Contract Research
1.2.3.3.1. Oncology
1.2.3.3.2. Cardiology
1.2.3.3.3. Neuroscience
1.2.3.3.4. Inflammation & Immunology
1.2.3.3.5. Others
1.2.4. Biopharmaceutical CMO and CRO Market By Product
1.2.4.1. Global Biopharmaceutical CMO and CRO Market Revenue and Growth Rate Comparison By Product (2015-2026)
1.2.4.2. Biosimilars
1.2.4.3. Biologics
1.2.4.4. Monoclonal Antibodies (MAbs)
1.2.4.5. Recombinant Proteins
1.2.4.6. Vaccines
1.2.4.7. Antisense, RNAi, & Molecular Therapy
1.2.4.8. Others
1.2.5. Biopharmaceutical CMO and CRO Market by Geography
1.2.5.1. Global Biopharmaceutical CMO and CRO Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.5.2. North America Biopharmaceutical CMO and CRO Market Revenue and Growth Rate (2015-2026)
1.2.5.3. Europe Biopharmaceutical CMO and CRO Market Revenue and Growth Rate (2015-2026)
1.2.5.4. Asia-Pacific Biopharmaceutical CMO and CRO Market Revenue and Growth Rate (2015-2026)
1.2.5.5. Latin America Biopharmaceutical CMO and CRO Market Revenue and Growth Rate (2015-2026)
1.2.5.6. Middle East and Africa (MEA) Biopharmaceutical CMO and CRO Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Biopharmaceutical CMO and CRO Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Biopharmaceutical CMO and CRO Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Biopharmaceutical CMO and CRO Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Biopharmaceutical CMO and CRO Major Manufacturers in 2017

CHAPTER 4. BIOPHARMACEUTICAL CMO AND CRO MARKET BY BY SOURCE

4.1. Global Biopharmaceutical CMO and CRO Revenue By Source
4.2. Non-mammalian
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Mammalian
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. BIOPHARMACEUTICAL CMO AND CRO MARKET BY SERVICE TYPE

5.1. Global Biopharmaceutical CMO and CRO Revenue By Service Type
5.2. Contract Manufacturing
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.2.3. Process Development
5.2.4. Analytical & QC studies
5.2.5. Finish & Fill Operations
5.2.6. Packaging
5.3. Contract Research
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3.3. Oncology
5.3.4. Cardiology
5.3.5. Neuroscience
5.3.6. Inflammation & Immunology
5.3.7. Others

CHAPTER 6. BIOPHARMACEUTICAL CMO AND CRO MARKET BY PRODUCT

6.1. Global Biopharmaceutical CMO and CRO Revenue By Product
6.2. Biosimilars
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Biologics
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Monoclonal Antibodies (MAbs)
6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.5. Recombinant Proteins
6.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.6. Vaccines
6.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.7. Antisense, RNAi, & Molecular Therapy
6.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.8. Others
6.8.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.8.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. NORTH AMERICA BIOPHARMACEUTICAL CMO AND CRO MARKET BY COUNTRY

7.1. North America Biopharmaceutical CMO and CRO Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America Biopharmaceutical CMO and CRO Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
7.3.1. U.S. Biopharmaceutical CMO and CRO Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Service Type, 2015 - 2026 ($Million)
7.3.3. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Service Type, 2015 - 2026 ($Million)
7.4.3. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.5. Mexico
7.5.1. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Service Type, 2015 - 2026 ($Million)
7.5.3. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

CHAPTER 8. EUROPE BIOPHARMACEUTICAL CMO AND CRO MARKET BY COUNTRY

8.1. Europe Biopharmaceutical CMO and CRO Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe Biopharmaceutical CMO and CRO Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Service Type, 2015 - 2026 ($Million)
8.3.3. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Service Type, 2015 - 2026 ($Million)
8.4.3. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Service Type, 2015 - 2026 ($Million)
8.5.3. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Service Type, 2015 - 2026 ($Million)
8.6.3. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Service Type, 2015 - 2026 ($Million)
8.7.3. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC BIOPHARMACEUTICAL CMO AND CRO MARKET BY COUNTRY

9.1. Asia-Pacific Biopharmaceutical CMO and CRO Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific Biopharmaceutical CMO and CRO Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Service Type, 2015 - 2026 ($Million)
9.3.3. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Service Type, 2015 - 2026 ($Million)
9.4.3. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Service Type, 2015 - 2026 ($Million)
9.5.3. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Service Type, 2015 - 2026 ($Million)
9.6.3. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Service Type, 2015 - 2026 ($Million)
9.7.3. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
9.8.2. Market Revenue and Forecast By Service Type, 2015 - 2026 ($Million)
9.8.3. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

CHAPTER 10. LATIN AMERICA BIOPHARMACEUTICAL CMO AND CRO MARKET BY COUNTRY

10.1. Latin America Biopharmaceutical CMO and CRO Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America Biopharmaceutical CMO and CRO Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Service Type, 2015 - 2026 ($Million)
10.3.3. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.4. Argentina
10.4.1. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Service Type, 2015 - 2026 ($Million)
10.4.3. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Service Type, 2015 - 2026 ($Million)
10.5.3. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

CHAPTER 11. MIDDLE EAST BIOPHARMACEUTICAL CMO AND CRO MARKET BY COUNTRY

11.1. Middle East Biopharmaceutical CMO and CRO Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East Biopharmaceutical CMO and CRO Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. Saudi Arabia
11.3.1. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Service Type, 2015 - 2026 ($Million)
11.3.3. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.4. UAE
11.4.1. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Service Type, 2015 - 2026 ($Million)
11.4.3. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.5. Rest of Middle East
11.5.1. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Service Type, 2015 - 2026 ($Million)
11.5.3. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

CHAPTER 12. AFRICA BIOPHARMACEUTICAL CMO AND CRO MARKET BY COUNTRY

12.1. Africa Biopharmaceutical CMO and CRO Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Africa Biopharmaceutical CMO and CRO Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. South Africa
12.3.1. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
12.3.2. Market Revenue and Forecast By Service Type, 2015 - 2026 ($Million)
12.3.3. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.4. Egypt
12.4.1. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
12.4.2. Market Revenue and Forecast By Service Type, 2015 - 2026 ($Million)
12.4.3. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.5. Rest of Africa
12.5.1. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
12.5.2. Market Revenue and Forecast By Service Type, 2015 - 2026 ($Million)
12.5.3. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

CHAPTER 13. COMPANY PROFILE

13.1. Boehringer Ingelheim GmbH
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Type Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. Lonza
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Type Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. Rentschler Biotechnologie GmbH
13.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Type Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. JRS Pharma (Celonic GmbH)
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Type Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. TOYOBO Biologics, LTD
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Type Portfolio
13.5.5. Key Developments
13.5.6. Strategies
13.6. FUJIFILM Diosynth Biotechnologies U.S.A.
13.6.1. Company Snapshot
13.6.2. Overview
13.6.3. Financial Overview
13.6.4. Type Portfolio
13.6.5. Key Developments
13.6.6. Strategies
13.7. Patheon
13.7.1. Company Snapshot
13.7.2. Overview
13.7.3. Financial Overview
13.7.4. Type Portfolio
13.7.5. Key Developments
13.7.6. Strategies
13.8. CMC Biologics
13.8.1. Company Snapshot
13.8.2. Overview
13.8.3. Financial Overview
13.8.4. Type Portfolio
13.8.5. Key Developments
13.8.6. Strategies
13.9. WuXi Biologics
13.9.1. Company Snapshot
13.9.2. Overview
13.9.3. Financial Overview
13.9.4. Type Portfolio
13.9.5. Key Developments
13.9.6. Strategies
13.10. Others
13.10.1. Company Snapshot
13.10.2. Overview
13.10.3. Financial Overview
13.10.4. Type Portfolio
13.10.5. Key Developments
13.10.6. Strategies

CHAPTER 14. RESEARCH APPROACH

14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research
14.2. Assumptions and Scope

Cart Summary